Tratamiento farmacológico antidepresivo en adultos mayores: Guía basada en síntesis de la evidencia

dc.contributorVillar Centeno, Juan Carlos
dc.contributorSantacruz, José Manuel
dc.contributorVillar Centeno, Juan Carlos [0000068519]
dc.contributorVillar Centeno, Juan Carlos [0000-0002-7047-7299]
dc.contributorVillar Centeno, Juan Carlos [Juan-Carlos-Villar-Centeno-2168464015]
dc.creatorPorras Angarita, Henry Alberto
dc.date.accessioned2021-08-12T13:36:29Z
dc.date.accessioned2022-09-28T19:11:45Z
dc.date.available2021-08-12T13:36:29Z
dc.date.available2022-09-28T19:11:45Z
dc.date.created2021-08-12T13:36:29Z
dc.date.issued2021
dc.identifierhttp://hdl.handle.net/20.500.12749/13787
dc.identifierinstname:Universidad Autónoma de Bucaramanga - UNAB
dc.identifierreponame:Repositorio Institucional UNAB
dc.identifierrepourl:https://repository.unab.edu.co
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3714141
dc.description.abstractLa depresión del adulto mayor es una patología con una alta prevalencia y complicaciones, en un grupo poblacional en constante crecimiento, que conlleva múltiples desafíos por la influencia de diferentes factores biopsicosociales que no están presentes en otros grupos poblacionales. Se asocia a un peor pronóstico, curso crónico, menor respuesta antidepresiva y mayor riesgo de recaída o recurrencia. El uso de fármacos antidepresivos en ancianos se ha correlacionado con efectos adversos importantes que podrían poner en riesgo la vida y que deben ser tenidos en cuenta a la hora de pautar el tratamiento. La información que actualmente existe en guías sobre el tratamiento farmacológico antidepresivo está centrada en la población general, no están basadas en evidencia o no están sintetizadas. Estas guías permiten transmitir la información de manera clara, sintetizada, y lleva a que los profesionales de la salud puedan tomar decisiones terapéuticas de manera más rápida, evitar complicaciones, prevenir un uso inapropiado de fármacos y mejorar las pautas de tratamiento en beneficio del adulto mayor.
dc.languagespa
dc.publisherUniversidad Autónoma de Bucaramanga UNAB
dc.publisherFacultad Ciencias de la Salud
dc.publisherMaestría en Métodos para la Producción y Aplicación de Conocimiento Científico en Salud
dc.relationAgüera-Ortiz, L., Claver-Martín, M. D., Franco-Fernández, M. D., López-Álvarez, J., Martín-Carrasco, M., Ramos-García, M. I., & Sánchez-Pérez, M. (2020). Depression in the Elderly. Consensus Statement of the Spanish Psychogeriatric Association. Frontiers in Psychiatry, 11. https://doi.org/10.3389/fpsyt.2020.00380
dc.relationAlhawassi, T. M., Alatawi, W., & Alwhaibi, M. (2019). Prevalence of potentially inappropriate medications use among older adults and risk factors using the 2015 American Geriatrics Society Beers criteria. BMC Geriatrics, 19(1), 154. https://doi.org/10.1186/s12877-019 1168-1
dc.relationAllard, P., Gram, L., Timdahl, K., Behnke, K., Hanson, M., & Søgaard, J. (2004). Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: A double-blind, randomised 6-month comparative trial with citalopram. International Journal of Geriatric Psychiatry, 19(12), 1123-1130. https://doi.org/10.1002/gps.1190
dc.relationAlmeida, O. P., Alfonso, H., Hankey, G. J., & Flicker, L. (2010). Depression, antidepressant use and mortality in later life: The Health In Men Study. PloS One, 5(6), e11266. https://doi.org/10.1371/journal.pone.0011266
dc.relationAmerican Psychological Association (APA). (2019). Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts American Psychological Association Guideline Development Panel for the Treatment of Depressive Disorders
dc.relationAnglin, R., Yuan, Y., Moayyedi, P., Tse, F., Armstrong, D., & Leontiadis, G. I. (2014). Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: A systematic review and meta-analysis. The American Journal of Gastroenterology, 109(6), 811-819. https://doi.org/10.1038/ajg.2014.82
dc.relationArtigas, F. (2013). Serotonin receptors involved in antidepressant effects. Pharmacology & Therapeutics, 137(1), 119-131. https://doi.org/10.1016/j.pharmthera.2012.09.006
dc.relationAvasthi, A., & Grover, S. (2018). Clinical Practice Guidelines for Management of Depression in Elderly. Indian Journal of Psychiatry, 60(Suppl 3), S341-S362. https://doi.org/10.4103/0019-5545.224474
dc.relationBains, J., Birks, J., & Dening, T. (2002). Antidepressants for treating depression in dementia. The Cochrane Database of Systematic Reviews, 4, CD003944. https://doi.org/10.1002/14651858.CD003944
dc.relationBajbouj, M., & Danker-Hopfe, H. (2006). Maintenance treatment of depression in old age. The New England Journal of Medicine, 354(23), 2505-2506; author reply 2505-2506
dc.relationBakken, M. S., Engeland, A., Engesæter, L. B., Ranhoff, A. H., Hunskaar, S., & Ruths, S. (2013). Increased risk of hip fracture among older people using antidepressant drugs: Data from the Norwegian Prescription Database and the Norwegian Hip Fracture Registry. Age and Ageing, 42(4), 514-520. https://doi.org/10.1093/ageing/aft009
dc.relationBanerjee, S., Hellier, J., Dewey, M., Romeo, R., Ballard, C., Baldwin, R., Bentham, P., Fox, C., Holmes, C., Katona, C., Knapp, M., Lawton, C., Lindesay, J., Livingston, G., McCrae, N., Moniz-Cook, E., Murray, J., Nurock, S., Orrell, M., … Burns, A. (2011). Sertraline or mirtazapine for depression in dementia (HTA-SADD): A randomised, multicentre, double blind, placebo-controlled trial. Lancet (London, England), 378(9789), 403-411. https://doi.org/10.1016/S0140-6736(11)60830-1
dc.relationBarbui, C., Esposito, E., & Cipriani, A. (2009). Selective serotonin reuptake inhibitors and risk of suicide: A systematic review of observational studies. CMAJ: Canadian Medical Association Journal = Journal de l’Association Medicale Canadienne, 180(3), 291-297. https://doi.org/10.1503/cmaj.081514
dc.relationBobo, W. V., Grossardt, B. R., Lapid, M. I., Leung, J. G., Stoppel, C., Takahashi, P. Y., Hoel, R. W., Chang, Z., Lachner, C., Chauhan, M., Flowers, L., Brue, S. M., Frye, M. A., St Sauver, J., Rocca, W. A., & Sutor, B. (2019). Frequency and predictors of the potential overprescribing of antidepressants in elderly residents of a geographically defined U.S. population. Pharmacology Research & Perspectives, 7(1), e00461. https://doi.org/10.1002/prp2.461
dc.relationBoström, G., Hörnsten, C., Brännström, J., Conradsson, M., Nordström, P., Allard, P., Gustafson, Y., & Littbrand, H. (2016). Antidepressant use and mortality in very old people. International Psychogeriatrics, 28(7), 1201-1210. https://doi.org/10.1017/S104161021600048X
dc.relationBrännström, J., Lövheim, H., Gustafson, Y., & Nordström, P. (2019). Association Between Antidepressant Drug Use and Hip Fracture in Older People Before and After Treatment Initiation. JAMA Psychiatry, 76(2), 172. https://doi.org/10.1001/jamapsychiatry.2018.3679
dc.relationBrzezińska, A., Bourke, J., Rivera-Hernández, R., Tsolaki, M., Woźniak, J., & Kaźmierski, J. (2020). Depression in Dementia or Dementia in Depression? Systematic Review of Studies and Hypotheses. Current Alzheimer Research, 17(1), 16-28. https://doi.org/10.2174/1567205017666200217104114
dc.relationBy the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. (2019). American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. Journal of the American Geriatrics Society, 67(4), 674-694. https://doi.org/10.1111/jgs.15767
dc.relationCenso Nacional de Población y Vivienda 2018. (s. f.). Recuperado 5 de octubre de 2020, de https://www.dane.gov.co/index.php/estadisticas-por-tema/demografia-y poblacion/censo-nacional-de-poblacion-y-vivenda-2018
dc.relationCheng, Y.-L., Hu, H.-Y., Lin, X.-H., Luo, J.-C., Peng, Y.-L., Hou, M.-C., Lin, H.-C., & Lee, F.-Y. (2015). Use of SSRI, But Not SNRI, Increased Upper and Lower Gastrointestinal Bleeding. Medicine, 94(46). https://doi.org/10.1097/MD.0000000000002022
dc.relationChoi, J. W., Lee, K. S., & Han, E. (2021). Suicide risk within 1 year of dementia diagnosis in older adults: A nationwide retrospective cohort study. Journal of Psychiatry & Neuroscience: JPN, 46(1), E119-E127. https://doi.org/10.1503/jpn.190219
dc.relationCipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., Egger, M., Takeshima, N., Hayasaka, Y., Imai, H., Shinohara, K., Tajika, A., Ioannidis, J. P. A., & Geddes, J. R. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis. Lancet (London, England), 391(10128), 1357-1366. https://doi.org/10.1016/S0140-6736(17)32802-7
dc.relationCorona, G., Giuliani, C., Parenti, G., Colombo, G. L., Sforza, A., Maggi, M., Forti, G., & Peri, A. (2016). The Economic Burden of Hyponatremia: Systematic Review and Meta-Analysis. The American Journal of Medicine, 129(8), 823-835.e4. https://doi.org/10.1016/j.amjmed.2016.03.007
dc.relationCorona, G., Norello, D., Parenti, G., Sforza, A., Maggi, M., & Peri, A. (2018). Hyponatremia, falls and bone fractures: A systematic review and meta-analysis. Clinical Endocrinology, 89(4), 505 513. https://doi.org/10.1111/cen.13790
dc.relationCoupland, C., Dhiman, P., Morriss, R., Arthur, A., Barton, G., & Hippisley-Cox, J. (2011). Antidepressant use and risk of adverse outcomes in older people: Population based cohort study. BMJ (Clinical Research Ed.), 343, d4551. https://doi.org/10.1136/bmj.d4551
dc.relationDavies, L. E., Spiers, G., Kingston, A., Todd, A., Adamson, J., & Hanratty, B. (2020). Adverse Outcomes of Polypharmacy in Older People: Systematic Review of Reviews. Journal of the 101 American Medical Directors Association, 21(2), 181-187. https://doi.org/10.1016/j.jamda.2019.10.022
dc.relationde Vasconcelos Cunha, U. G., Lopes Rocha, F., Avila de Melo, R., Alves Valle, E., de Souza Neto, J. J., Mendes Brega, R., Magalhães Scoralick, F., Araújo Silva, S., Martins de Oliveira, F., da Costa Júnior, A. L., Faria Alves, V. X., & Sakurai, E. (2007). A placebo-controlled double-blind randomized study of venlafaxine in the treatment of depression in dementia. Dementia and Geriatric Cognitive Disorders, 24(1), 36-41. https://doi.org/10.1159/000102570
dc.relationDiem, S. J., Blackwell, T. L., Stone, K. L., Cauley, J. A., Hillier, T. A., Haney, E. M., & Ensrud, K. E. (2011). Use of Antidepressant Medications and Risk of Fracture in Older Women. Calcified tissue international, 88(6), 476-484. https://doi.org/10.1007/s00223-011-9481-5
dc.relationDriscoll, H. C., Basinski, J., Mulsant, B. H., Butters, M. A., Dew, M. A., Houck, P. R., Mazumdar, S., Miller, M. D., Pollock, B. G., Stack, J. A., Schlernitzauer, M. A., & Reynolds, C. F. (2005). Late-onset major depression: Clinical and treatment-response variability. International Journal of Geriatric Psychiatry, 20(7), 661-667. https://doi.org/10.1002/gps.1334
dc.relationDu, Y., Wolf, I.-K., Busch, M. A., & Knopf, H. (2019). Associations between the use of specific psychotropic drugs and all-cause mortality among older adults in Germany: Results of the mortality follow-up of the German National Health Interview and Examination Survey 1998. PloS One, 14(1), e0210695. https://doi.org/10.1371/journal.pone.0210695
dc.relationDudas, R., Malouf, R., McCleery, J., & Dening, T. (2018). Antidepressants for treating depression in dementia. The Cochrane Database of Systematic Reviews, 8, CD003944. https://doi.org/10.1002/14651858.CD003944.pub2
dc.relationEmeny, R. T., Chang, C.-H., Skinner, J., O’Malley, A. J., Smith, J., Chakraborti, G., Rosen, C. J., & Morden, N. E. (2019). Association of Receiving Multiple, Concurrent Fracture-Associated 102 Drugs With Hip Fracture Risk. JAMA Network Open, 2(11), e1915348. https://doi.org/10.1001/jamanetworkopen.2019.15348
dc.relationEnache, D., Fereshtehnejad, S.-M., Kåreholt, I., Cermakova, P., Garcia-Ptacek, S., Johnell, K., Religa, D., Jelic, V., Winblad, B., Ballard, C., Aarsland, D., Fastbom, J., & Eriksdotter, M. (2016). Antidepressants and mortality risk in a dementia cohort: Data from SveDem, the Swedish Dementia Registry. Acta Psychiatrica Scandinavica, 134(5), 430-440. https://doi.org/10.1111/acps.12630
dc.relationEom, C.-S., Lee, H.-K., Ye, S., Park, S. M., & Cho, K.-H. (2012). Use of selective serotonin reuptake inhibitors and risk of fracture: A systematic review and meta-analysis. Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research, 27(5), 1186-1195. https://doi.org/10.1002/jbmr.1554
dc.relationFabian, T. J., Amico, J. A., Kroboth, P. D., Mulsant, B. H., Corey, S. E., Begley, A. E., Bensasi, S. G., Weber, E., Dew, M. A., Reynolds, C. F., & Pollock, B. G. (2004). Paroxetine-induced hyponatremia in older adults: A 12-week prospective study. Archives of Internal Medicine, 164(3), 327-332. https://doi.org/10.1001/archinte.164.3.327
dc.relationFarmand, S., Lindh, J. D., Calissendorff, J., Skov, J., Falhammar, H., Nathanson, D., & Mannheimer, B. (2018). Differences in Associations of Antidepressants and Hospitalization Due to Hyponatremia. The American Journal of Medicine, 131(1), 56-63. https://doi.org/10.1016/j.amjmed.2017.07.025
dc.relationFergusson, D., Doucette, S., Glass, K. C., Shapiro, S., Healy, D., Hebert, P., & Hutton, B. (2005). Association between suicide attempts and selective serotonin reuptake inhibitors: Systematic review of randomised controlled trials. BMJ : British Medical Journal, 330(7488), 396
dc.relationFurukawa, T. A., Cipriani, A., Cowen, P. J., Leucht, S., Egger, M., & Salanti, G. (2019). Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: A systematic review and dose-response meta-analysis. The Lancet. Psychiatry, 6(7), 601-609. https://doi.org/10.1016/S2215-0366(19)30217-2
dc.relationGandhi, S., Shariff, S. Z., Al-Jaishi, A., Reiss, J. P., Mamdani, M. M., Hackam, D. G., Li, L., McArthur, E., Weir, M. A., & Garg, A. X. (2017). Second-Generation Antidepressants and Hyponatremia Risk: A Population-Based Cohort Study of Older Adults. American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation, 69(1), 87-96. https://doi.org/10.1053/j.ajkd.2016.08.020
dc.relationGonzález Quiñones, J. C. (2017). Resumen: «Sabe Colombia 2015: Estudio Nacional de Salud, Bienestar y Envejecimiento». Carta Comunitaria, 25(144), 24.
dc.relationGorwood, P., Weiller, E., Lemming, O., & Katona, C. (2007). Escitalopram prevents relapse in older patients with major depressive disorder. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry, 15(7), 581-593. https://doi.org/10.1097/01.JGP.0000240823.94522.4c
dc.relationGøtzsche, P. C., & Dinnage, O. (2020). What have antidepressants been tested for? A systematic review. The International Journal of Risk & Safety in Medicine, 31(3), 157-163. https://doi.org/10.3233/JRS-200006
dc.relationGrayson, L., & Thomas, A. (2013). A systematic review comparing clinical features in early age at onset and late age at onset late-life depression. Journal of Affective Disorders, 150(2), 161 170. https://doi.org/10.1016/j.jad.2013.03.021
dc.relationGutiérrez-Rojas, L., Porras-Segovia, A., Dunne, H., Andrade-González, N., & Cervilla, J. A. (2020). Prevalence and correlates of major depressive disorder: A systematic review. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil: 1999). https://doi.org/10.1590/1516-4446 2020-0650
dc.relationHedna, K., Andersson Sundell, K., Hensing, G., Skoog, I., Gustavsson, S., & Waern, M. (2018). Late life suicidal behaviours among new users of antidepressants: A prospective population based study of sociodemographic and gender factors in those aged 75 and above. BMJ Open, 8(10). https://doi.org/10.1136/bmjopen-2018-022703
dc.relationHedna, K., Hensing, G., Skoog, I., Fastbom, J., & Waern, M. (2020). Sociodemographic and gender determinants of late-life suicide in users and non-users of antidepressants. The European Journal of Public Health, 30(5), 958-964. https://doi.org/10.1093/eurpub/ckaa114
dc.relationHedrick, R., Korouri, S., Tadros, E., Darwish, T., Cortez, V., Triay, D., Pasini, M., Olanisa, L., Herrera, N., Hanna, S., Kimchi, A., Hamilton, M., Danovitch, I., & IsHak, W. W. (2020). The impact of antidepressants on depressive symptom severity, quality of life, morbidity, and mortality in heart failure: A systematic review. Drugs in Context, 9. https://doi.org/10.7573/dic.2020-5-4
dc.relationHegeman, J. M., Kok, R. M., Mast, R. C. van der, & Giltay, E. J. (2012). Phenomenology of depression in older compared with younger adults: Meta-analysis. The British Journal of Psychiatry, 200(4), 275-281. https://doi.org/10.1192/bjp.bp.111.095950
dc.relationHengartner, M. P., Amendola, S., Kaminski, J. A., Kindler, S., Bschor, T., & Plöderl, M. (2020). Suicide risk with selective serotonin reuptake inhibitors and new-generation serotonergic noradrenergic antidepressants in adults: A systematic review and meta-analysis of observational studies. MedRxiv, 2020.05.11.20098178. https://doi.org/10.1101/2020.05.11.20098178
dc.relationHenssler, J., Kurschus, M., Franklin, J., Bschor, T., & Baethge, C. (2018). Trajectories of Acute Antidepressant Efficacy: How Long to Wait for Response? A Systematic Review and Meta 105 Analysis of Long-Term, Placebo-Controlled Acute Treatment Trials. The Journal of Clinical Psychiatry, 79(3). https://doi.org/10.4088/JCP.17r11470
dc.relationJeuring, H. W., Stek, M. L., Huisman, M., Oude Voshaar, R. C., Naarding, P., Collard, R. M., van der Mast, R. C., Kok, R. M., Beekman, A. T. F., & Comijs, H. C. (2018). A Six-Year Prospective Study of the Prognosis and Predictors in Patients With Late-Life Depression. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry, 26(9), 985-997. https://doi.org/10.1016/j.jagp.2018.05.005
dc.relationJiang, H.-Y., Chen, H.-Z., Hu, X.-J., Yu, Z.-H., Yang, W., Deng, M., Zhang, Y.-H., & Ruan, B. (2015). Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: A systematic review and meta-analysis. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association, 13(1), 42 50.e3. https://doi.org/10.1016/j.cgh.2014.06.021
dc.relationKasper, S., de Swart, H., & Friis Andersen, H. (2005). Escitalopram in the treatment of depressed elderly patients. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry, 13(10), 884-891. https://doi.org/10.1176/appi.ajgp.13.10.884
dc.relationKatona, C., Hansen, T., & Olsen, C. K. (2012). A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder: International Clinical Psychopharmacology, 27(4), 215-223. https://doi.org/10.1097/YIC.0b013e3283542457
dc.relationKhanassov, V., Hu, J., Reeves, D., & van Marwijk, H. (2018). Selective serotonin reuptake inhibitor and selective serotonin and norepinephrine reuptake inhibitor use and risk of fractures in adults: A systematic review and meta-analysis. International Journal of Geriatric Psychiatry, 33(12), 1688-1708. https://doi.org/10.1002/gps.4974
dc.relationKlysner, R., Bent-Hansen, J., Hansen, H. L., Lunde, M., Pleidrup, E., Poulsen, D. L., Andersen, M., & Petersen, H. E. H. (2002). Efficacy of citalopram in the prevention of recurrent depression in elderly patients: Placebo-controlled study of maintenance therapy. The British Journal of Psychiatry: The Journal of Mental Science, 181, 29-35. https://doi.org/10.1192/bjp.181.1.29
dc.relationKok, R. M., Nolen, W. A., & Heeren, T. J. (2012). Efficacy of treatment in older depressed patients: A systematic review and meta-analysis of double-blind randomized controlled trials with antidepressants. Journal of Affective Disorders, 141(2-3), 103-115. https://doi.org/10.1016/j.jad.2012.02.036
dc.relationKoKoAung, E., Cavenett, S., McArthur, A., & Aromataris, E. (2015). The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: A systematic review. JBI Database of Systematic Reviews and Implementation Reports, 13(3), 174-205. https://doi.org/10.11124/jbisrir-2015-2272
dc.relationKollhorst, B., Jobski, K., Krappweis, J., Schink, T., Garbe, E., & Schmedt, N. (2019). Antidepressants and the risk of death in older patients with depression: A population-based cohort study. PLOS ONE, 14(4), e0215289. https://doi.org/10.1371/journal.pone.0215289
dc.relationKrause, M., Gutsmiedl, K., Bighelli, I., Schneider-Thoma, J., Chaimani, A., & Leucht, S. (2019). Efficacy and tolerability of pharmacological and non-pharmacological interventions in older patients with major depressive disorder: A systematic review, pairwise and network meta-analysis. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology, 29(9), 1003-1022. https://doi.org/10.1016/j.euroneuro.2019.07.130
dc.relationKumar, M., Bajpai, R., Shaik, A. R., Srivastava, S., & Vohora, D. (2020). Alliance between selective serotonin reuptake inhibitors and fracture risk: An updated systematic review and meta 107 analysis. European Journal of Clinical Pharmacology, 76(10), 1373-1392. https://doi.org/10.1007/s00228-020-02893-1
dc.relationKuring, J. K., Mathias, J. L., & Ward, L. (2018). Prevalence of Depression, Anxiety and PTSD in People with Dementia: A Systematic Review and Meta-Analysis. Neuropsychology Review, 28(4), 393-416. https://doi.org/10.1007/s11065-018-9396-2
dc.relationLam, R. W., Kennedy, S. H., Grigoriadis, S., McIntyre, R. S., Milev, R., Ramasubbu, R., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009). Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults.: III. Pharmacotherapy. Journal of Affective Disorders, 117, S26-S43. https://doi.org/10.1016/j.jad.2009.06.041
dc.relationLanteigne, A., Sheu, Y., Stürmer, T., Pate, V., Azrael, D., Swanson, S. A., & Miller, M. (2015). Serotonin-Norepinephrine Reuptake Inhibitor and Selective Serotonin Reuptake Inhibitor Use and Risk of Fractures: A new-user cohort study among US adults aged 50 and older. CNS drugs, 29(3), 245-252. https://doi.org/10.1007/s40263-015-0231-5
dc.relationLeach, M. J., Pratt, N. L., & Roughead, E. E. (2017). Risk of Hip Fracture in Older People Using Selective Serotonin Reuptake Inhibitors and Other Psychoactive Medicines Concurrently: A Matched Case-Control Study in Australia. Drugs - Real World Outcomes, 4(2), 87-96. https://doi.org/10.1007/s40801-017-0107-8
dc.relationLeipzig, R. M., Cumming, R. G., & Tinetti, M. E. (1999). Drugs and falls in older people: A systematic review and meta-analysis: I. Psychotropic drugs. Journal of the American Geriatrics Society, 47(1), 30-39. https://doi.org/10.1111/j.1532-5415.1999.tb01898.x
dc.relationeth-Møller, K. B., Hansen, A. H., Torstensson, M., Andersen, S. E., Ødum, L., Gislasson, G., Torp Pedersen, C., & Holm, E. A. (2016). Antidepressants and the risk of hyponatremia: A Danish 108 register-based population study. BMJ Open, 6(5), e011200. https://doi.org/10.1136/bmjopen-2016-011200
dc.relationLi, J.-Q., Tan, L., Wang, H.-F., Tan, M.-S., Tan, L., Xu, W., Zhao, Q.-F., Wang, J., Jiang, T., & Yu, J.-T. (2016). Risk factors for predicting progression from mild cognitive impairment to Alzheimer’s disease: A systematic review and meta-analysis of cohort studies. Journal of Neurology, Neurosurgery, and Psychiatry, 87(5), 476-484. https://doi.org/10.1136/jnnp 2014-310095
dc.relationLicht-Strunk, E., van der Windt, D. A., van Marwijk, H. W., de Haan, M., & Beekman, A. T. (2007). The prognosis of depression in older patients in general practice and the community. A systematic review. Family Practice, 24(2), 168-180. https://doi.org/10.1093/fampra/cml071
dc.relationLivingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., Costafreda, S. G., Dias, A., Fox, N., Gitlin, L. N., Howard, R., Kales, H. C., Kivimäki, M., Larson, E. B., Ogunniyi, A., … Mukadam, N. (2020). Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet, 396(10248), 413-446. https://doi.org/10.1016/S0140-6736(20)30367-6
dc.relationLoke, Y. K., Trivedi, A. N., & Singh, S. (2007). Meta-analysis: Gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti inflammatory drugs: META-ANALYSIS: GASTROINTESTINAL BLEEDING WITH SSRIS AND NSAID. Alimentary Pharmacology & Therapeutics, 27(1), 31-40. https://doi.org/10.1111/j.1365-2036.2007.03541.x
dc.relationLombardi, G., Ferraro, P. M., Calvaruso, L., Naticchia, A., D’Alonzo, S., & Gambaro, G. (2019). Sodium Fluctuations and Mortality in a General Hospitalized Population. Kidney & Blood Pressure Research, 44(4), 604-614. https://doi.org/10.1159/000500916
dc.relationLuppa, M., Sikorski, C., Luck, T., Ehreke, L., Konnopka, A., Wiese, B., Weyerer, S., König, H.-H., & Riedel-Heller, S. G. (2012). Age- and gender-specific prevalence of depression in latest life—Systematic review and meta-analysis. Journal of Affective Disorders, 136(3), 212-221. https://doi.org/10.1016/j.jad.2010.11.033
dc.relationLuzecky, M. H., Burman, K. D., & Schultz, E. R. (1974). The syndrome of inappropriate secretion of antidiuretic hormone associated with amitriptyline administration. Southern Medical Journal, 67(4), 495-497. https://doi.org/10.1097/00007611-197404000-00027
dc.relationLyketsos, C. G., DelCampo, L., Steinberg, M., Miles, Q., Steele, C. D., Munro, C., Baker, A. S., Sheppard, J.-M. E., Frangakis, C., Brandt, J., & Rabins, P. V. (2003). Treating depression in Alzheimer disease: Efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. Archives of General Psychiatry, 60(7), 737-746. https://doi.org/10.1001/archpsyc.60.7.737
dc.relationMahar, I., Bambico, F. R., Mechawar, N., & Nobrega, J. N. (2014). Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects. Neuroscience and Biobehavioral Reviews, 38, 173-192. https://doi.org/10.1016/j.neubiorev.2013.11.009
dc.relationMallery, L., MacLeod, T., Allen, M., McLean-Veysey, P., Rodney-Cail, N., Bezanson, E., Steeves, B., LeBlanc, C., & Moorhouse, P. (2019). Systematic review and meta-analysis of second generation antidepressants for the treatment of older adults with depression: Questionable benefit and considerations for frailty. BMC Geriatrics, 19(1), 306. https://doi.org/10.1186/s12877-019-1327-4
dc.relationMannesse, C. K., Vondeling, A. M., van Marum, R. J., van Solinge, W. W., Egberts, T. C. G., & Jansen, P. A. F. (2013). Prevalence of hyponatremia on geriatric wards compared to other 110 settings over four decades: A systematic review. Ageing Research Reviews, 12(1), 165-173. https://doi.org/10.1016/j.arr.2012.04.006
dc.relationMinisterio de Salud y Protección Social - Colciencias. (2013). Guía de práctica clínica Detección temprana y diagnóstico del episodio depresivo y trastorno depresivo recurrente en adultos. Atención integral de los adultos con diagnóstico de episodio depresivo o trastorno depresivo recurrente. https://medicosgeneralescolombianos.com/images/Guias_2013/gpc_22prof_sal_depre.p df
dc.relationMitchell, A. J., & Subramaniam, H. (2005). Prognosis of depression in old age compared to middle age: A systematic review of comparative studies. The American Journal of Psychiatry, 162(9), 1588-1601. https://doi.org/10.1176/appi.ajp.162.9.1588
dc.relationMottram, P., Wilson, K., & Strobl, J. (2006). Antidepressants for depressed elderly. The Cochrane Database of Systematic Reviews, 1, CD003491. https://doi.org/10.1002/14651858.CD003491.pub2
dc.relationMovig, K. L. L., Leufkens, H. G. M., Lenderink, A. W., & Egberts, A. C. G. (2002). Serotonergic antidepressants associated with an increased risk for hyponatraemia in the elderly. European Journal of Clinical Pharmacology, 58(2), 143-148. https://doi.org/10.1007/s00228-002-0438-5
dc.relationMukai, Y., & Tampi, R. R. (2009). Treatment of depression in the elderly: A review of the recent literature on the efficacy of single- versus dual-action antidepressants. Clinical Therapeutics, 31(5), 945-961. https://doi.org/10.1016/j.clinthera.2009.05.016
dc.relationMurthy, K., Ondrey, G. J., Malkani, N., Raman, G., Hodge, M. B., Marcantonio, A. J., & Verbalis, J. G. (2019). THE EFFECTS OF HYPONATREMIA ON BONE DENSITY AND FRACTURES: A SYSTEMATIC REVIEW AND META-ANALYSIS. Endocrine Practice: Official Journal of the 111 American College of Endocrinology and the American Association of Clinical Endocrinologists, 25(4), 366-378. https://doi.org/10.4158/EP-2018-0499
dc.relationNelson, J. C., Delucchi, K., & Schneider, L. S. (2008a). Efficacy of second generation antidepressants in late-life depression: A meta-analysis of the evidence. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry, 16(7), 558 567. https://doi.org/10.1097/JGP.0b013e3181693288
dc.relationNelson, J. C., Delucchi, K., & Schneider, L. S. (2008b). Efficacy of Second Generation Antidepressants in Late-Life Depression: A Meta-Analysis of the Evidence. The American Journal of Geriatric Psychiatry, 16(7), 558-567. https://doi.org/10.1097/01.JGP.0000308883.64832.ed
dc.relationNelson, J. C., & Devanand, D. P. (2011). A systematic review and meta-analysis of placebo controlled antidepressant studies in people with depression and dementia. Journal of the American Geriatrics Society, 59(4), 577-585. https://doi.org/10.1111/j.1532 5415.2011.03355.x
dc.relationNervenheilkunde (DGPPN), D. G. F. P., Psychotherapie Und, & Ärztliches Zentrum Für Qualität In Der Medizin (ÄZQ). (2015). S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression—Langfassung, 2. Auflage [Text/pdf]. Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN); Bundesärztekammer (BÄK); Kassenärztliche Bundesvereinigung (KBV); Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). https://doi.org/10.6101/AZQ/000364
dc.relationOderda, L. H., Young, J. R., Asche, C. V., & Pepper, G. A. (2012). Psychotropic-related hip fractures: Meta-analysis of first-generation and second-generation antidepressant and antipsychotic drugs. The Annals of Pharmacotherapy, 46(7-8), 917-928. https://doi.org/10.1345/aph.1Q589
dc.relationOka, Y., Okamoto, K., Kawashita, N., Shirakuni, Y., & Takagi, T. (2014). Meta-analysis of the Risk of Upper Gastrointestinal Hemorrhage with Combination Therapy of Selective Serotonin Reuptake Inhibitors and Non-steroidal Anti-inflammatory Drugs. Biological and Pharmaceutical Bulletin, 37(6), 947-953. https://doi.org/10.1248/bpb.b13-00885
dc.relationO’Mahony, D., O’Sullivan, D., Byrne, S., O’Connor, M. N., Ryan, C., & Gallagher, P. (2015). STOPP/START criteria for potentially inappropriate prescribing in older people: Version 2. Age and Ageing, 44(2), 213-218. https://doi.org/10.1093/ageing/afu145
dc.relationOrgeta, V., Tabet, N., Nilforooshan, R., & Howard, R. (2017). Efficacy of Antidepressants for Depression in Alzheimer’s Disease: Systematic Review and Meta-Analysis. Journal of Alzheimer’s Disease: JAD, 58(3), 725-733. https://doi.org/10.3233/JAD-161247
dc.relationPeeters, C. M. M., Visser, E., Van de Ree, C. L. P., Gosens, T., Den Oudsten, B. L., & De Vries, J. (2016). Quality of life after hip fracture in the elderly: A systematic literature review. Injury, 47(7), 1369-1382. https://doi.org/10.1016/j.injury.2016.04.018
dc.relationPohl, P., Nordin, E., Lundquist, A., Bergström, U., & Lundin-Olsson, L. (2014). Community-dwelling older people with an injurious fall are likely to sustain new injurious falls within 5 years—A prospective long-term follow-up study. BMC Geriatrics, 14, 120. https://doi.org/10.1186/1471-2318-14-120
dc.relationPractice guideline for the treatment of patients with major depressive disorder, third edition Clinical Practice Guidelines. (s. f.). Guideline Central. Recuperado 12 de octubre de 2020, de https://www.guidelinecentral.com/summaries/practice-guideline-for-the-treatment of-patients-with-major-depressive-disorder-third-edition
dc.relationPrieto-Alhambra, D., Petri, H., Goldenberg, J. S. B., Khong, T. P., Klungel, O. H., Robinson, N. J., & de Vries, F. (2014). Excess risk of hip fractures attributable to the use of antidepressants in five European countries and the USA. Osteoporosis International: A Journal Established as 113 Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 25(3), 847-855. https://doi.org/10.1007/s00198-013-2612-2
dc.relationRabenda, V., Nicolet, D., Beaudart, C., Bruyère, O., & Reginster, J.-Y. (2013). Relationship between use of antidepressants and risk of fractures: A meta-analysis. Osteoporosis International: A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 24(1), 121-137. https://doi.org/10.1007/s00198-012-2015-9
dc.relationRajeswaran, T., Plymen, C. M., & Doherty, A. M. (2018). The effect of antidepressant medications in the management of heart failure on outcomes: Mortality, cardiovascular function and depression - a systematic review. International Journal of Psychiatry in Clinical Practice, 22(3), 164-169. https://doi.org/10.1080/13651501.2017.1401085
dc.relationRaskin, J., Wiltse, C. G., Dinkel, J. J., Walker, D. J., Desaiah, D., & Katona, C. (2008). Safety and tolerability of duloxetine at 60 mg once daily in elderly patients with major depressive disorder. Journal of Clinical Psychopharmacology, 28(1), 32-38. https://doi.org/10.1097/jcp.0b013e318160738e
dc.relationReynolds, C. F., Dew, M. A., Frank, E., Begley, A. E., Miller, M. D., Cornes, C., Mazumdar, S., Perel, J. M., & Kupfer, D. J. (1998). Effects of age at onset of first lifetime episode of recurrent major depression on treatment response and illness course in elderly patients. The American Journal of Psychiatry, 155(6), 795-799. https://doi.org/10.1176/ajp.155.6.795
dc.relationReynolds, Charles F., Dew, M. A., Pollock, B. G., Mulsant, B. H., Frank, E., Miller, M. D., Houck, P. R., Mazumdar, S., Butters, M. A., Stack, J. A., Schlernitzauer, M. A., Whyte, E. M., Gildengers, A., Karp, J., Lenze, E., Szanto, K., Bensasi, S., & Kupfer, D. J. (2006). Maintenance treatment 114 of major depression in old age. The New England Journal of Medicine, 354(11), 1130-1138. https://doi.org/10.1056/NEJMoa052619
dc.relationRobinson, M., Oakes, T. M., Raskin, J., Liu, P., Shoemaker, S., & Nelson, J. C. (2014). Acute and Long-term Treatment of Late-Life Major Depressive Disorder: Duloxetine Versus Placebo. The American Journal of Geriatric Psychiatry, 22(1), 34-45. https://doi.org/10.1016/j.jagp.2013.01.019
dc.relationRosenberg, P. B., Drye, L. T., Martin, B. K., Frangakis, C., Mintzer, J. E., Weintraub, D., Porsteinsson, A. P., Schneider, L. S., Rabins, P. V., Munro, C. A., Meinert, C. L., & Lyketsos, C. G. (2010). Sertraline for the treatment of depression in Alzheimer’s disease. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 18(2), 136-145. https://doi.org/10.1097/JGP.0b013e3181c796eb
dc.relationRyan, J., Carriere, I., Ritchie, K., Stewart, R., Toulemonde, G., Dartigues, J.-F., Tzourio, C., & Ancelin, M.-L. (2008). Late-life depression and mortality: Influence of gender and antidepressant use. The British Journal of Psychiatry: The Journal of Mental Science, 192(1), 12-18. https://doi.org/10.1192/bjp.bp.107.039164
dc.relationSchatzberg, A., & Roose, S. (2006). A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry, 14(4), 361-370. https://doi.org/10.1097/01.JGP.0000194645.70869.3b
dc.relationSeitz, D. P., Adunuri, N., Gill, S. S., Gruneir, A., Herrmann, N., & Rochon, P. (2011). Antidepressants for agitation and psychosis in dementia. The Cochrane Database of Systematic Reviews, 2, CD008191. https://doi.org/10.1002/14651858.CD008191.pub2
dc.relationSeppala, L. J., Wermelink, A. M. A. T., de Vries, M., Ploegmakers, K. J., van de Glind, E. M. M., Daams, J. G., van der Velde, N., & EUGMS task and Finish group on fall-risk-increasing 115 drugs. (2018). Fall-Risk-Increasing Drugs: A Systematic Review and Meta-Analysis: II. Psychotropics. Journal of the American Medical Directors Association, 19(4), 371.e11 371.e17. https://doi.org/10.1016/j.jamda.2017.12.098
dc.relationSeyfried, L. S., Kales, H. C., Ignacio, R. V., Conwell, Y., & Valenstein, M. (2011). Predictors of suicide in patients with dementia. Alzheimer’s & dementia : the journal of the Alzheimer’s Association, 7(6), 567-573. https://doi.org/10.1016/j.jalz.2011.01.006
dc.relationSjöberg, L., Karlsson, B., Atti, A.-R., Skoog, I., Fratiglioni, L., & Wang, H.-X. (2017). Prevalence of depression: Comparisons of different depression definitions in population-based samples of older adults. Journal of Affective Disorders, 221, 123-131. https://doi.org/10.1016/j.jad.2017.06.011
dc.relationSmith, D., Dempster, C., Glanville, J., Freemantle, N., & Anderson, I. (2002). Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: A meta-analysis. The British Journal of Psychiatry: The Journal of Mental Science, 180, 396-404. https://doi.org/10.1192/bjp.180.5.396
dc.relationTedeschini, E., Levkovitz, Y., Iovieno, N., Ameral, V. E., Nelson, J. C., & Papakostas, G. I. (2011). Efficacy of antidepressants for late-life depression: A meta-analysis and meta-regression of placebo-controlled randomized trials. The Journal of Clinical Psychiatry, 72(12), 1660-1668. https://doi.org/10.4088/JCP.10r06531
dc.relationTham, A., Jonsson, U., Andersson, G., Söderlund, A., Allard, P., & Bertilsson, G. (2016a). Efficacy and tolerability of antidepressants in people aged 65 years or older with major depressive disorder—A systematic review and a meta-analysis. Journal of Affective Disorders, 205, 1 12. https://doi.org/10.1016/j.jad.2016.06.013
dc.relationTham, A., Jonsson, U., Andersson, G., Söderlund, A., Allard, P., & Bertilsson, G. (2016b). Efficacy and tolerability of antidepressants in people aged 65 years or older with major depressive 116 disorder—A systematic review and a meta-analysis. Journal of Affective Disorders, 205, 1 12. https://doi.org/10.1016/j.jad.2016.06.013
dc.relationThompson, S., Herrmann, N., Rapoport, M. J., & Lanctôt, K. L. (2007). Efficacy and safety of antidepressants for treatment of depression in Alzheimer’s disease: A metaanalysis. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie, 52(4), 248-255. https://doi.org/10.1177/070674370705200407
dc.relationThorlund, K., Druyts, E., Wu, P., Balijepalli, C., Keohane, D., & Mills, E. (2015). Comparative efficacy and safety of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors in older adults: A network meta-analysis. Journal of the American Geriatrics Society, 63(5), 1002-1009. https://doi.org/10.1111/jgs.13395
dc.relationTorvinen-Kiiskinen, S., Tolppanen, A.-M., Koponen, M., Tanskanen, A., Tiihonen, J., Hartikainen, S., & Taipale, H. (2017). Antidepressant use and risk of hip fractures among community dwelling persons with and without Alzheimer’s disease. International Journal of Geriatric Psychiatry, 32(12), e107-e115. https://doi.org/10.1002/gps.4667
dc.relationUpala, S., & Sanguankeo, A. (2016). Association Between Hyponatremia, Osteoporosis, and Fracture: A Systematic Review and Meta-analysis. The Journal of Clinical Endocrinology and Metabolism, 101(4), 1880-1886. https://doi.org/10.1210/jc.2015-4228
dc.relationVida, S., Des Rosiers, P., Carrier, L., & Gauthier, S. (1994). Prevalence of depression in Alzheimer’s disease and validity of Research Diagnostic Criteria. Journal of Geriatric Psychiatry and Neurology, 7(4), 238-244. https://doi.org/10.1177/089198879400700409
dc.relationWatt, J. A., Goodarzi, Z., Veroniki, A. A., Nincic, V., Khan, P. A., Ghassemi, M., Thompson, Y., Lai, Y., Treister, V., Tricco, A. C., & Straus, S. E. (2020). Safety of pharmacologic interventions for neuropsychiatric symptoms in dementia: A systematic review and network meta-analysis. BMC Geriatrics, 20. https://doi.org/10.1186/s12877-020-01607-7
dc.relationWHO | The global burden of disease: 2004 update. (s. f.). WHO; World Health Organization. Recuperado 11 de octubre de 2020, de https://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/
dc.relationWilkinson, P., & Izmeth, Z. (2012). Continuation and maintenance treatments for depression in older people. The Cochrane Database of Systematic Reviews, 11, CD006727. https://doi.org/10.1002/14651858.CD006727.pub2
dc.relationWilkinson, P., & Izmeth, Z. (2016). Continuation and maintenance treatments for depression in older people. The Cochrane Database of Systematic Reviews, 9, CD006727. https://doi.org/10.1002/14651858.CD006727.pub3
dc.relationWilson, K. C. M., Mottram, P. G., Ashworth, L., & Abou-Saleh, M. T. (2003). Older community residents with depression: Long-term treatment with sertraline: Randomised, double blind, placebo-controlled study. The British Journal of Psychiatry, 182(6), 492-497. https://doi.org/10.1192/bjp.182.6.492
dc.relationWilson, K., Mottram, P. G., Sivananthan, A., & Nightingale, A. (2001). Antidepressants versus placebo for the depressed elderly. The Cochrane Database of Systematic Reviews, 2001(1). https://doi.org/10.1002/14651858.CD000561
dc.relationWorld Population Prospects—Population Division—United Nations. (s. f.). Recuperado 5 de octubre de 2020, de https://population.un.org/wpp
dc.relationZhou, C., Fang, L., Chen, Y., Zhong, J., Wang, H., & Xie, P. (2018). Effect of selective serotonin reuptake inhibitors on bone mineral density: A systematic review and meta-analysis. Osteoporosis International: A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 29(6), 1243-1251. https://doi.org/10.1007/s00198-018-4413-0
dc.relationZiere, G., Dieleman, J. P., van der Cammen, T. J. M., Hofman, A., Pols, H. A. P., & Stricker, B. H. C. (2008). Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures. Journal of Clinical Psychopharmacology, 28(4), 411-417. https://doi.org/10.1097/JCP.0b013e31817e0ecb
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rightsAbierto (Texto Completo)
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttp://purl.org/coar/access_right/c_abf2
dc.rightsAtribución-NoComercial-SinDerivadas 2.5 Colombia
dc.titleTratamiento farmacológico antidepresivo en adultos mayores: Guía basada en síntesis de la evidencia
dc.typeThesis


Este ítem pertenece a la siguiente institución